Clinical trial of IDX 719 + IDX 184 in patients with hepatitis C

Next Previous
Trial Profile

Clinical trial of IDX 719 + IDX 184 in patients with hepatitis C

Discontinued
Phase of Trial: Phase II

Latest Information Update: 04 Feb 2013

At a glance

  • Drugs IDX 184 (Primary) ; Samatasvir (Primary)
  • Indications Hepatitis C
  • Focus Therapeutic Use

    • Most Recent Events

    • 23 Apr 2012 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top